Wegovy Slashes the Risk of Heart Attack and Stroke in a Landmark Trial https://media.wired.com/photos/654ec8225c5bbfd14d7b4d2c/master/pass/Wegovy-Heart-Disease-Science-1692436399.jpg The drug semaglutide is already widely used for weight loss. Now its maker is presenting new evidence that it can reduce cardiovascular illnesses and deaths. https://www.wired.com/story/wegovy-slashes-the-risk-of-heart-attack-and-stroke-in-a-landmark-trial/